Pricing Log in Create free account

PureTech Health PLC Sponsored ADR (PRTCY) vs ARS Pharmaceuticals, Inc. (SPRY)

PureTech Health PLC Sponsored ADR and ARS Pharmaceuticals, Inc. are both Biotechnology companies. PureTech Health PLC Sponsored ADR and ARS Pharmaceuticals, Inc. are of similar size ($424.0M and $404.8M). PureTech Health PLC Sponsored ADR grew revenue faster over the last twelve months: 28.5% against 4.08%. ARS Pharmaceuticals, Inc. has the higher net margin (−184.3% vs −199.4%) and the lower return on invested capital (−335.7% vs 0.00%). Across the 15 metrics below, PureTech Health PLC Sponsored ADR leads on 11 and ARS Pharmaceuticals, Inc. on 4.

Valuation

Metric PRTCY SPRY Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.37 9.71
P/B n/m 31.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.81 n/m 0.64
EV/Sales (9.10) 3.61 9.21
Earnings yield (1.48%) (54.91%) (33.15%)
Free cash flow yield 0.00% (53.80%) (25.50%)

Profitability

Metric PRTCY SPRY Biotechnology median
Gross margin 0.00% 71.37% 65.16%
Operating margin 0.00% (184.96%) 0.00%
Net margin (199.36%) (184.26%) 0.00%
Free cash flow margin 0.00% (167.97%) 0.00%
Return on equity 0.00% (210.37%) (56.36%)
Return on assets 0.00% (76.54%) (48.04%)
Return on invested capital 0.00% (335.65%) 0.00%

Growth

Metric PRTCY SPRY Biotechnology median
Revenue growth (TTM) 28.48% 4.08% 6.02%
EPS growth (last fiscal year) (2,277.05%) (2,275.00%) 30.26%
Revenue growth, 5-year CAGR (16.92%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRTCY SPRY Biotechnology median
Debt to equity 0.00 13.72 0.00
Current ratio 6.59 3.48 4.72
Net debt to EBITDA 3.03 0.42 0.96

Dividend

Metric PRTCY SPRY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PRTCY SPRY Biotechnology median
Market cap 424.00m 404.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack